Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposity

European Journal of Nutrition

Volumn 57, Issue 3, 2018, Pages 965-979

  Hira, Tohru ^a   Suto, Ryoya ^a   Kishimoto, Yuka ^b   Kanahori, Sumiko ^b   Hara, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Matsutani Chemical Industry Co   (Japan)

Author keywords

Adiposity; Appetite; Fructooligosaccharides; Glucagon like peptide 1; High fat and high sucrose diet; Resistant maltodextrin

Indexed keywords

ACETIC ACID; BUTYRIC ACID; FAT; FRUCTOSE OLIGOSACCHARIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MALTODEXTRIN; MESSENGER RNA; PROPIONIC ACID; SUCROSE; ANOREXIGENIC AGENT; OLIGOSACCHARIDE; POLYSACCHARIDE; PREBIOTIC AGENT; VOLATILE FATTY ACID;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BODY WEIGHT GAIN; CALORIC INTAKE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID ANALYSIS; GLUCOSE TOLERANCE; HIGH-SUCROSE DIET; INSULIN RESISTANCE; INSULIN RESPONSE; INTRA-ABDOMINAL FAT; LIPID DIET; MALE; MRNA EXPRESSION LEVEL; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN CONTENT; PROTEIN SECRETION; RAT; AGONISTS; ANIMAL; BLOOD; CECUM; CHEMISTRY; DIGESTION; DYSBIOSIS; FERMENTATION; GENE EXPRESSION REGULATION; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT; STOMACH JUICE; WESTERN DIET;

ADIPOSITY; ANIMALS; APPETITE DEPRESSANTS; CECUM; DIET, WESTERN; DIGESTION; DYSBIOSIS; ENERGY INTAKE; FATTY ACIDS, VOLATILE; FERMENTATION; GASTROINTESTINAL CONTENTS; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; INTESTINAL MUCOSA; INTRA-ABDOMINAL FAT; MALE; OBESITY; OLIGOSACCHARIDES; ORGAN SIZE; POLYSACCHARIDES; PREBIOTICS; RATS, SPRAGUE-DAWLEY;

EID: 85011610009     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-017-1381-7     Document Type: Article

References (56)

1. Cho YM, Fujita Y, Kieffer TJ (2014) Glucagon-like peptide-1: glucose homeostasis and beyond. Annu Rev Physiol 76:535–559. doi:10.1146/annurev-physiol-021113-170315
2. Kim YO, Schuppan D (2012) When GLP-1 hits the liver: a novel approach for insulin resistance and NASH. Am J Physiol Gastrointest Liver Physiol 302(8):G759–G761. doi:10.1152/ajpgi.00078.2012
3. Nauck M (2016) Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes Obes Metab 18(3):203–216. doi:10.1111/dom.12591
4. Diakogiannaki E, Gribble FM, Reimann F (2012) Nutrient detection by incretin hormone secreting cells. Physiol Behav 106(3):387–393. doi:10.1016/j.physbeh.2011.12.001
5. Higuchi N, Hira T, Yamada N, Hara H (2013) Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and goto-kakizaki rats. Endocrinology 154(9):3089–3098. doi:10.1210/en.2012-2275
6. Ishikawa Y, Hira T, Inoue D, Harada Y, Hashimoto H, Fujii M, Kadowaki M, Hara H (2015) Rice protein hydrolysates stimulate GLP-1 secretion, reduce GLP-1 degradation, and lower the glycemic response in rats. Food Funct 6(8):2525–2534. doi:10.1039/c4fo01054j
7. Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A, Reimann F, Holst JJ, Gribble FM (2009) Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr 89(1):106–113. doi:10.3945/ajcn.2008.26362
8. Jakubowicz D, Froy O, Ahrén B, Boaz M, Landau Z, Bar-Dayan Y, Ganz T, Barnea M, Wainstein J (2014) Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia 57(9):1807–1811. doi:10.1007/s00125-014-3305-x
9. Hira T, Ikee A, Kishimoto Y, Kanahori S, Hara H (2015) Resistant maltodextrin promotes fasting glucagon-like peptide-1 secretion and production together with glucose tolerance in rats. Br J Nutr 114(1):34–42. doi:10.1017/S0007114514004322
10. Cani PD, Dewever C, Delzenne NM (2004) Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92(3):521–526
11. Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM (2005) Involvement of endogenous glucagon-like peptide-1(7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol 185(3):457–465. doi:10.1677/joe.1.06100
12. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM (2005) Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93(Suppl 1):S157–S161
13. Fastinger ND, Karr-Lilienthal LK, Spears JK, Swanson KS, Zinn KE, Nava GM, Ohkuma K, Kanahori S, Gordon DT, Fahey GC (2008) A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans. J Am Coll Nutr 27(2):356–366
14. Reimer RA, Russell JC (2008) Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring) 16(1):40–46. doi:10.1038/oby.2007.16
15. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ (2008) Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295(5):E1160–E1166. doi:10.1152/ajpendo.90637.2008
16. Hashizume C, Kishimoto Y, Kanahori S, Yamamoto T, Okuma K, Yamamoto K (2012) Improvement effect of resistant maltodextrin in humans with metabolic syndrome by continuous administration. J Nutr Sci Vitaminol (Tokyo) 58(6):423–430
17. Livesey G, Tagami H (2009) Interventions to lower the glycemic response to carbohydrate foods with a low-viscosity fiber (resistant maltodextrin): meta-analysis of randomized controlled trials. Am J Clin Nutr 89(1):114–125. doi:10.3945/ajcn.2008.26842
18. Chu HF, Pan MH, Ho CT, Tseng YH, Wang WW, Chau CF (2014) Variations in the efficacy of resistant maltodextrin on body fat reduction in rats fed different high-fat models. J Agric Food Chem 62(1):192–197. doi:10.1021/jf404809v
19. Ye Z, Arumugam V, Haugabrooks E, Williamson P, Hendrich S (2015) Soluble dietary fiber (Fibersol-2) decreased hunger and increased satiety hormones in humans when ingested with a meal. Nutr Res 35(5):393–400. doi:10.1016/j.nutres.2015.03.004
20. Adam CL, Gratz SW, Peinado DI, Thomson LM, Garden KE, Williams PA, Richardson AJ, Ross AW (2016) Effects of dietary fibre (Pectin) and/or increased protein (Casein or Pea) on satiety, body weight, adiposity and caecal fermentation in high fat diet-induced obese rats. PLoS One 11(5):e0155871. doi:10.1371/journal.pone.0155871
21. den Besten G, Gerding A, van Dijk TH, Ciapaite J, Bleeker A, van Eunen K, Havinga R, Groen AK, Reijngoud DJ, Bakker BM (2015) Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor γ and glucagon-like peptide-1. PLoS One 10(8):e0136364. doi:10.1371/journal.pone.0136364
22. Adam CL, Williams PA, Dalby MJ, Garden K, Thomson LM, Richardson AJ, Gratz SW, Ross AW (2014) Different types of soluble fermentable dietary fibre decrease food intake, body weight gain and adiposity in young adult male rats. Nutr Metab (Lond) 11:36. doi:10.1186/1743-7075-11-36
23. Parnell JA, Reimer RA (2012) Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 3(1):29–34. doi:10.4161/gmic.19246
24. Cluny NL, Eller LK, Keenan CM, Reimer RA, Sharkey KA (2015) Interactive effects of oligofructose and obesity predisposition on gut hormones and microbiota in diet-induced obese rats. Obesity (Silver Spring) 23(4):769–778. doi:10.1002/oby.21017
25. Turner ND, Lupton JR (2011) Dietary fiber. Adv Nutr 2(2):151–152. doi:10.3945/an.110.000281
26. Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127(5 Suppl):838 S–841 S
27. Cani PD, Hoste S, Guiot Y, Delzenne NM (2007) Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 98(1):32–37. doi:10.1017/S0007114507691648
28. Iwaya H, Lee JS, Yamagishi S, Shinoki A, Lang W, Thawornkuno C, Kang HK, Kumagai Y, Suzuki S, Kitamura S, Hara H, Okuyama M, Mori H, Kimura A, Ishizuka S (2012) The delay in the development of experimental colitis from isomaltosyloligosaccharides in rats is dependent on the degree of polymerization. PLoS One 7(11):e50658. doi:10.1371/journal.pone.0050658
29. Miyazato S, Nakagawa C, Kishimoto Y, Tagami H, Hara H (2010) Promotive effects of resistant maltodextrin on apparent absorption of calcium, magnesium, iron and zinc in rats. Eur J Nutr 49(3):165–171. doi:10.1007/s00394-009-0062-6
30. Cacho J, Sevillano J, de Castro J, Herrera E, M. P. Ramos (2108) Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 295:E1269–E1276. doi:10.1152/ajpendo.90207.2008
31. Tappy L, Lê KA (2010) Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90(1):23–46. doi:10.1152/physrev.00019.2009
32. Micha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG, Engell RE, Powles J, Ezzati M, Mozaffarian D, NutriCoDE GBoDNaCDEG (2014) Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 348:g2272. doi:10.1136/bmj.g2272
33. Lai M, Chandrasekera PC, Barnard ND (2014) You are what you eat, or are you? The challenges of translating high-fat-fed rodents to human obesity and diabetes. Nutr Diabetes 4:e135. doi:10.1038/nutd.2014.30
34. Nakajima S, Hira T, Hara H (2015) Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats. Br J Nutr 113(9):1477–1488. doi:10.1017/S0007114515000550
35. Theodorakis MJ (2015) Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525. Diabetes 64(9):e28–29. doi:10.2337/db15-0614. (discussion e30–21)
36. Færch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, Pedersen O, Hansen T, Lauritzen T, Sandbæk A, Holst JJ, Jørgensen ME (2015) GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: The ADDITION-PRO Study. Diabetes 64(7):2513–2525. doi:10.2337/db14-1751
37. Smushkin G, Sathananthan A, Man CD, Zinsmeister AR, Camilleri M, Cobelli C, Rizza RA, Vella A (2012) Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab 97(2):589–598. doi:10.1210/jc.2011-2561
38. Numao S, Kawano H, Endo N, Yamada Y, Konishi M, Takahashi M, Sakamoto S (2012) Short-term low carbohydrate/high-fat diet intake increases postprandial plasma glucose and glucagon-like peptide-1 levels during an oral glucose tolerance test in healthy men. Eur J Clin Nutr 66(8):926–931. doi:10.1038/ejcn.2012.58
39. Trevaskis JL, Griffin PS, Wittmer C, Neuschwander-Tetri BA, Brunt EM, Dolman CS, Erickson MR, Napora J, Parkes DG, Roth JD (2012) Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 302(8):G762–G772. doi:10.1152/ajpgi.00476.2011
40. Wu H, Sui C, Xu H, Xia F, Zhai H, Zhang H, Weng P, Han B, Du S, Lu Y (2014) The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp. J Diabetes Res 2014:524517. doi:10.1155/2014/524517
41. Kishimoto Y, Oga H, Tagami H, Okuma K, Gordon DT (2007) Suppressive effect of resistant maltodextrin on postprandial blood triacylglycerol elevation. Eur J Nutr 46(3):133–138. doi:10.1007/s00394-007-0643-1
42. Beylot M (2005) Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 93(Suppl 1):S163–S168
43. Phuwamongkolwiwat P, Suzuki T, Hira T, Hara H (2014) Fructooligosaccharide augments benefits of quercetin-3-O-β-glucoside on insulin sensitivity and plasma total cholesterol with promotion of flavonoid absorption in sucrose-fed rats. Eur J Nutr 53(2):457–468. doi:10.1007/s00394-013-0546-2
44. Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R (2006) Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55(5):1484–1490
45. Cani PD, Neyrinck AM, Maton N, Delzenne NM (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 13(6):1000–1007. doi:10.1038/oby.2005.117
46. Verhoef SP, Meyer D, Westerterp KR (2011) Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 106(11):1757–1762. doi:10.1017/S0007114511002194
47. Liber A, Szajewska H (2013) Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials. Ann Nutr Metab 63(1–2):42–54. doi:10.1159/000350312
48. Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, Frost GS (2013) Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study. Appetite 66:44–53. doi:10.1016/j.appet.2013.02.017
49. Daud NM, Ismail NA, Thomas EL, Fitzpatrick JA, Bell JD, Swann JR, Costabile A, Childs CE, Pedersen C, Goldstone AP, Frost GS (2014) The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity (Silver Spring) 22(6):1430–1438. doi:10.1002/oby.20754
50. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61(2):364–371. doi:10.2337/db11-1019
51. Psichas A, Sleeth ML, Murphy KG, Brooks L, Bewick GA, Hanyaloglu AC, Ghatei MA, Bloom SR, Frost G (2015) The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) 39(3):424–429. doi:10.1038/ijo.2014.153
52. Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S, Frost G (2015) Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64(11):1744–1754. doi:10.1136/gutjnl-2014-307913
53. Byrne CS, Chambers ES, Morrison DJ, Frost G (2015) The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond) 39(9):1331–1338. doi:10.1038/ijo.2015.84
54. Svendsen B, Pedersen J, Albrechtsen NJ, Hartmann B, Toräng S, Rehfeld JF, Poulsen SS, Holst JJ (2015) An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology 156(3):847–857. doi:10.1210/en.2014-1710
55. Rouillé Y, Kantengwa S, Irminger JC, Halban PA (1997) Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1. J Biol Chem 272(52):32810–32816
56. Morimoto K, Watanabe M, Sugizaki T, Irie J, Itoh H (2016) Intestinal bile acid composition modulates prohormone convertase 1/3 (PC1/3) expression and consequent GLP-1 production in male mice. Endocrinology 157(3):1071–1081. doi:10.1210/en.2015-1551